Vimarsana
Biggest News Aggregation in the World

Page 32 - Irtschaft News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Irtschaft. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Irtschaft Today - Breaking & Trending Today

Enapter Receives Grant of around 1 Million Euros from the Italian Ministry of Ecological Transition - Vimarsana News

Enapter Receives Grant of around 1 Million Euros from the Italian Ministry of Ecological Transition

28.07.2022 Enapter Receives Grant of around 1 Million Euros from the Italian Ministry of Ecological Transition | Enapter AG | News | Nachricht | Mitteilung

Source: dgap.de
ENCAVIS AG refinances solar park portfolio in the Netherlands - Vimarsana News

ENCAVIS AG refinances solar park portfolio in the Netherlands

28.07.2022 ENCAVIS AG refinances solar park portfolio in the Netherlands | ENCAVIS AG | News | Nachricht | Mitteilung

Source: dgap.de
Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China - Vimarsana News

Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China

28.07.2022 Cosmo and 3SBio Announce Signing of License Agreement for Winlevi® in China | Cosmo Pharmaceuticals N.V. | News | Nachricht | Mitteilung

Source: dgap.de
Befesa S.A.: Befesa continues to deliver with 25% yoy EBITDA growth and €118m in H1, despite volatile market environment - Vimarsana News

Befesa S.A.: Befesa continues to deliver with 25% yoy EBITDA growth and €118m in H1, despite volatile market environment

28.07.2022 Befesa S.A.: Befesa continues to deliver with 25% yoy EBITDA growth and €118m in H1, despite volatile market environment | Befesa S.A. | News | Nachricht | Mitteilung

Source: dgap.de
Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance - Vimarsana News

Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance

28.07.2022 Cosmo reports strong half-year 2022 financial results delivering record revenues and reaffirms 2022 full-year guidance | Cosmo Pharmaceuticals N.V. | News | Nachricht | Mitteilung

Source: dgap.de